Rick Fuller is an independent pharmaceutical consultant for drug development companies. Rick had a robust career of over 20 years as a physician with clinical development experience across multiple therapeutic areas including pulmonology, clinical pharmacology, and allergic disease, and he currently works as a CMO to multiple client companies. He has worked to make multiple IND submissions, held agency meetings, made orphan drug designations, and acted as first-in-human through pivotal trial design and execution. Rick serves as a clinical development consultant to bio-pharmaceutical companies that require highly skilled, hands-on physician support primarily in early-stage clinical development. His duties in this role include due diligence of product candidates, fundraising, supporting of IND filing (including leadership at FDA and other agency meetings), design and medical oversight of clinical trials in multiple therapeutic areas, creation of clinical development plans and associated activities and management of the expansion of the clinical and clinical operations infrastructure as required over time. Rick currently works in Interim (consultant) clinical development roles at the Medical Director, VP, or CMO level, independent Board seats, and strategic advisory roles.